Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 12th, 2015% Heartbuds device (Orlando Health)
12 November 2015. A device added to ordinary smartphones was found in a clinical trial to transmit cardiovascular sounds as well as professional stethoscopes used by clinicians, and better than FDA-approved disposable stethoscopes. Developers of the Heartbuds device and app, from Orlando Health, a health care provider in Florida, . . . → Read More: Smartphone Add-On Found Comparable to Pro Stethoscopes
By Alan, on November 11th, 2015% (bfishadow, WikimediaCommons)
11 November 2015. Voyager Therapeutics, a company less that two years old developing gene therapies for central nervous system disorders is raising $70 million in its initial public stock offering. The Cambridge, Massachusetts enterprise, trading on the Nasdaq exchange (symbol: VYGR), offered 5 million shares yesterday at $14.00. Shares closed today . . . → Read More: Gene Therapy Company Raises $70 Million in IPO
By Alan, on November 11th, 2015% Updated 21 November 2015. The survey is now closed. Thank you for taking part.
If you plan on taking part in the survey, please do so today. By participating, you’ll be helping me improve Science and Enterprise and contributing to the science of blog readership.
For completing the survey, each participant will receive a free . . . → Read More: Survey Ending on 20 November 2015
By Alan, on November 11th, 2015% Scanning electron microscope image of Acinetobacter baumannii bacteria (CDC.gov)
11 November 2015. Washington State University engineers and medical researchers developed an electronic stimulation patch that in lab tests kills nearly all drug-resistant bacteria it contacts. The team from the lab of bioengineering professor Haluk Beyenal published its proof-of-concept findings in a recent issue . . . → Read More: Electronic Patch Shown to Kill Drug-Resistant Bacteria
By Alan, on November 10th, 2015% Aerial view of smog over Mexico City in December 2010 (Fidel Gonzalez, Wikimedia Commons)
10 November 2015. A start-up company is licensing research from University of Copenhagen in Denmark to develop a technology for removing air pollution from city neighborhoods. The air cleaning technology, known as gas phase advanced oxidation, is a product . . . → Read More: Start-Up’s Air Quality Technology to Clean City Areas
By Alan, on November 10th, 2015% Paula Cannon (University of Southern California)
10 November 2015. A lab at University of Southern California and biotechnology company developed a technique for editing genomes in blood-forming stem cells as a potential treatment for HIV infection. The team from the lab of USC medical school professor Paula Cannon and Sangamo BioSciences in Richmond, . . . → Read More: USC, Biotech Edit Genes in Stem Cells for HIV Therapy
By Alan, on November 9th, 2015% (National Heart, Lung, and Blood Institute, NIH)
9 November 2015. A biotechnology company says it plans to focus its technology platform on a cancer-causing gene previously considered beyond the direct reach of today’s cancer drugs. Warp Drive Bio, in Cambridge, Massachusetts told an American Association of Cancer Research meeting in Boston on Saturday . . . → Read More: Biotech Targets “Undruggable” Cancer Gene
By Alan, on November 6th, 2015% U.S. Air Force doctor examining elderly patient in Honduras. (U.S. Southern Command)
6 November 2015. A biochemical and medical research team discovered a steroid that when given as eye drops to mice, reverses the accumulation of protein formations in cataracts. Researchers from the labs of protein chemistry professor Jason Gestwicki at University of . . . → Read More: Compound Found to Reverse Lens Clouding in Cataracts
By Alan, on November 5th, 2015% Physicist Stephen Hawking in 2013 with David Fleming, manager of the Intel Innovation Open Lab in Ireland, center, and Martin Curley, vice president of Intel Labs Europe (Intel Free Press/Flickr)
5 November 2015. Participants from universities in the U.S. and Taiwan are winners of a challenge to develop mathematical models that predict variations . . . → Read More: Winners of ALS Variation Models Challenge Announced
By Alan, on November 5th, 2015% Red blood cells held together with platelets, in blue, and fibrin, in yellow (NIH.gov)
5 November 2015. A biochemistry lab at University of British Columbia developed a technique for supercharging blood platelets with genetic material, enabling these cells to deliver therapies through the blood stream. The team led by biochemist and molecular biologist . . . → Read More: Platelets Engineered to Deliver, Transcribe RNA
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.